UMIN ID: UMIN000017250
Registered date:01/05/2015
Vitrectomy combined with intravitreal triamcinolone acetonide injection for diabetic macular edema
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Diabetic macular edema |
| Date of first enrollment | 2015/05/01 |
| Target sample size | 60 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Intra-Vitreal Triamcinolone Acetonide Vitrectormy |
Outcome(s)
| Primary Outcome | Central retinal thickness |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | History of previous vitrectomy. Previous history of treatment with agents including triamcninolone acetonide, anti-VEGF therapy, immunosuppressant drugs and artificial dialysis within 24 weeks. Modification of insulin treatments within 12 weeks. Previous history of laser treatments or intraocular surgery within 12 weeks. Previous history of systemic drugs such as steroid, carbonate dehydratase inhibitor and warfarin within 4 weeks. |
Related Information
| Primary Sponsor | Tohoku University Graduate School of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Wakamoto Pharmaceutical Co.,Ltd. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Hiroshi Kunikata |
| Address | 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan Japan |
| Telephone | 022-717-7294 |
| kunikata@oph.med.tohoku.ac.jp | |
| Affiliation | Tohoku University Graduate School of Medicine Department of Ophthalmology |
| scientific contact | |
| Name | Toru Nakazawa |
| Address | 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan Japan |
| Telephone | 022-717-7294 |
| ntoru@oph.med.tohoku.ac.jp | |
| Affiliation | Tohoku University Graduate School of Medicine Department of Ophthalmology |